Referentielijst

Ahmedzai S (1997)
Ahmedzai S, Davis C. Nebulised drugs in palliative care. Thorax 1997; 52 (Suppl 2): S75-S77.
 
Allard P (1999)
Allard P, Lamontagne C, Bernard P et al. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. Journal of Pain and Symptom Management 1999; 17: 256-265.
 
American Thoracic Society (1999)
American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Journal of Respiratory and Critical Care Medicine 1999; 159: 321-340.
 
Baltzan MA (2000)
Baltzan MA, Alter MA, Rotaple M et al. Fan to palliatie exerciceinduced dyspnea with severe COPD. American Journal of Respiratory and Critical Care Medicine 2000; 161 (suppl 3): A59.

Ben-Aharon I (2008)
Ben-Aharon I, Gafter-Gvili A, Paul M et al. Interventions for alleviating cancer-related dyspnea: a systematic review. Journal of Clinical Oncology 2008; 26: 2396-2404.

Bausewein C (2007)
Bausewein C, Farquhar M, Booth S et al. Measurement of breathlessness in advanced disease: A systematic review. Respir Med. 2007 Mar;101(3):399-410

Bausewein C (2008)
Bausewein C, Booth S, Gysels M et al. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant disease. Cochrane Database of Systematic Reviews 2008; 2: CD005623.

Bausewein C (2010a)
Bausewein C, Booth S, Gysels M, et al. Individual breathlessness trajectories do not match summary trajectories in advanced cancer and chronic obstructive pulmonary disease: results from a longitudinal study. Palliat Med 2010; 24: 777-786.

Bausewein C (2010b)
Bausewein C, Booth S, Gysels M, et al. Effectiveness of a hand-held fan for breathlessness: a randomised phase II trial. BMC Palliat Care. 2010 Oct 19;9:22

Booth S (2003)
Booth S, Silvester S, Todd C.Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care. 2003;1(4):337-344.

Booth S (2008)
Booth S, Moosavi SH, Higginson IJ. The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. National Clinical Practice in Oncology 2008; 5: 90-100.

Booth S (2011)
Booth S, Moffat C, Burkin J, et al. Nonpharmacological interventions for breathlessness. Curr Opin Support Palliat Care. 2011 Jun;5(2):77-86.
 
Bredin M (1999)
Bredin M, Corner J, Krishnasamy M et al. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. British Medical Journal 1999; 318: 901-904.
 
Bruce DM (1996)
Bruce DM, Heys SD, Eremin O. Lymphangitis carcinomatosa: a literature review. Journal of the Royal College of Surgeons Edinborough 1996; 41: 7-13.
 
Bruera E (1992)
Bruera E, Schoeller T, MacEachern T. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. Journal of Pain and Symptom Management 1992; 7: 365-368.
 
Connors S (2007)
Connors S, Graham S, Peel T. An evaluation of a physiotherapy led non-pharmacological breathlessness programme for patients with intrathoracic malignancy. Palliative Medicine 2007; 21: 285-287.
 
Corner J (1996)
Corner J, Plant H, A’Hern R et al. Non-pharmacological intervention for breathlessness in lung cancer. Palliative Medicine 1996; 10: 299-305.
 
Cranston JM (2005)
Cranston JM, Crockett A, Moss JR et al. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2005; 4: CD001744.
 
Currow DC (2009)
Currow DC, Agar M, Smith J et al. Does palliative home oxygen improve dyspnoea? A consecutive cohort study. Palliative Medicine 2009; 23: 309-316.
 
DiSalvo WM (2008)
DiSalvo WM, Joyce MM, Tyson LB et al. Putting evidence into practice: evidence-based interventions for cancer-related dyspnea. Clinical Journal of Oncology Nursing 2008; 12: 341-352.
 
Dorman S (2007)
Dorman S, Byrne A, Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliative Medicine 2007; 21: 177-191.
 
Dudgeon DJ (2001)
Dudgeon DJ, Kristjanson L, Sloan JA et al. Dyspnea in cancer patients: prevalence and associated factors. Journal of Pain and Symptom Management 2001; 21: 95-102.
 
Freedman S (1987)
Freedman S. Facial cooling and perception of dyspnoea. Lancet 1987; 2(8569): 1215.

Górecka D (1997)
Górecka D, Gorzelak K, Sliwi?ski P et al. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997; 52: 674-679
 
Hately J (2003)
Hately J, Laurence V, Scott A et al. Breathlessness clinics within specialist palliative care settings can improve the quality of life and functional capacity of patients with lung cancer. Palliative Medicine 2003; 17: 410-417.

Homsi J (2007)
Homsi J, Luong D. Symptoms and survival in patients with advanced disease. J Palliat Med 2007; 10: 904-909.

Hui D (2013a)
Hui D, Morgadeo M, Vidal M, et al. Dyspnea in hospitalized cancer patients: subjective and physiologic correlates. J Palliat Med. 2013 Mar;16(3):274-80.

Hui D (2013b)
Hui D, Morgado M, Chisholm G, Withers L, Nguyen Q, Finch C, et al. High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial. J Pain Symptom Manage 2013; 46(4): 463-73.

Jennings AL (2002)
Jennings AL, Davies AN, Higgings JP et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002; 57: 939-944.
 
Johnson M (2003)
Johnson M, Moore S. Research into practice: the reality of implementing a non-pharmacological breathlessness intervention into clinical practice. European Journal of Oncology Nursing 2003; 7: 33-38.
 
Kollef MH (1990)
Kollef MH, Johnson RC. Transtracheal gas administration and the perception of dyspnea. Respiratory Care 1990; 35: 791-799.
 
Kvale PA (2003)
Kvale PA, Simoff M, Prakash UB et al. Lung cancer. Palliative care. Chest 2003; 123: 284S-311S.
 
Liss HP (1988)
Liss HP, Grant BJ. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. American Review of Respiratory Diseases 1988; 137: 1285-1288.
 
Navigante AH (2006)
Navigante AH, Cerchietti LC, Castro MA et al. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. Journal of Pain and Symptom Management 2006; 31: 38-47.
 
Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose/Kwaliteitsinstituut voor de Gezondheidszorg CBO (2000)
Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose/Kwaliteitsinstituut voor de Gezondheidszorg CBO (CBO). Richtlijn Zuurstofbehandeling thuis. Utrecht: 2000.

Parshall MB (2012)
Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435-452.
 
De Peuter S (2004)
De Peuter S, Van Diest I, Lemaigre V, Verleden G, Demedts M, van den Bergh O. Dyspnea: the role of psychological processes. Clin Psychol Rev 2004; 24: 557-581.
  
Rocker GM (2007)
Rocker GM, Sinuff T, Horton R et al. Advanced chronic obstructive pulmonary disease: innovative approaches to palliation. Journal of Palliative Medicine 2007; 10: 783-797.

Schwartzstein RM (1988)
Schwartzstein RM, Lahive K, Pope A et al. Cold facial stimulation reduces breathlessness induced in normal subjects. American Review of Respiratory Diseases 1988; 136: 58-61.

Simon ST (2014)
Simon ST, Weingärtner V, Higginson IJ, et al. Definition, categorization, and terminology of episodic breathlessness: consensus by an international Delphi survey. J Pain Symptom Manage. 2014; 47(5): 828-638.

Smith EL (2001)
Smith EL, Hann DM, Ahles TA et al. Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. Journal of Pain and Symptom Management 2001; 21: 323-329.

Spreeuwenberg C (2013)
Spreeuwenberg C, Vissers K, Raats I, et al. Zorgmodule palliatieve zorg. Coördinatieplatform Zorgstandaarden en het Kwaliteitsinstituut Ministerie van Volksgezondheid, Welzijn en Sport, 2013.

Tataryn D (2002)
Tataryn D, Chochinov HM.Predicting the trajectory of will to live in terminally ill patients. Psychosomatics. 2002; 43: 370-377.

Thomas JR (2002)
Thomas JR, Gunten von CF. Clinical management of dyspnoea. Lancet Oncology 2002; 3: 223-228.

Uronis HE (2008)
Uronis HE, Currow DC, McCrory DC et al. Oxygen for the relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. British Journal of Cancer 2008; 98: 294-299.

Viola R (2008)
Viola R, Kiteley C, Lloyd NS et al. The management of dyspnea in cancer patients: a systematic review. Supportive Care in Cancer 2008; 16: 329-337.

Van den Aardweg JG (2013)
Van den Aardweg JG. 4 soorten dyspneu. Ned Tijdschr Geneeskd 2013;157: A5415.

Vora VA (2004)
Vora VA, Ahmedzai SH. Pulse oximetry in supportive and palliative care. Supportive Care in Cancer 2004; 12: 758-761.
 
Wymenga AN (2003)
Wymenga AN, Werf van der TS, Sleijfer DTh. Dyspnoe bij kankerpatiënten: oorzaken en therapie. Nederlands Tijdschrift voor Palliatieve Zorg 2003; 4: 49-54.
 

Currow DC (2010)
Currow DC, Smith J, Davidson PM, et al. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage 2010;39(4):680-690.
 
Janssen DJ (2008)
Janssen DJ, Spruit MA, Wouters EF, et al. Daily symptom burden in end-stage chronic organ failure: a systematic review. Palliat Med 2008;22(8):938-48.
 
Moens K (2014)
Moens K, Higginson IJ, Harding R. Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. J Pain Symptom Manage 2014; 48: 660-77.
 
Solano JP (2006)
Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006;31(1):58-69.
 
Teunissen SC (2007)
Teunissen SC, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007;34(1):94-104.
 
Weingärtner V (2015)
Weingärtner V, Scheve C, Gerdes V, et al. Characteristics of episodic breathlessness as reported by patients with advanced chronic obstructive pulmonary disease and lung cancer: Results of a descriptive cohort study. Palliat Med 2015; Jan 29. pii: 0269216314563428. [Epub ahead of print].
 
Lansing RW (2009)
Lansing RW, Cracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypothesis. Respir Physiol Neurobiol. 2009 May 30;167(1):53-60.
 
Nishino T (2011)
Nishino T. Dyspnoea: underlying mechanisms and treatment. Br J Anaesth. 2011 Apr;106(4):463-74.
 
De Peuter S (2004)
De Peuter S, Van Diest I, Lemaigre V, et al. Dyspnea: the role of psychological processes. Clin Psychol Rev. 2004 Sep;24(5):557-81.

Shadd J (2009)
Shadd J, Dudgeon D. Dyspnea. In: Walsh D. Palliative medicine. Philadelphia: Saunders, Elsevier, 2009, pp 877-881
 
Wymenga ANM (2003)
Wymenga ANM, Van der Werf TS, Sleijfer DT. Dyspnoe bij kankerpatiënten: oorzaken en therapie. Ned Tijdschr Palliat Zorg 2003; 4: 49-53
 
Chan K (2011)
Chan K, Tse D et al. Palliative medicine in malignant respiratory disease. In: Hanks G et al. Oxford handbook of palliative medicine. Oxford University Press, 2011, pp 1113-7.
 
Chang VT (2000)
Chang, Hwang SS, Feuermann M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000 May 1;88(9):2164-71.
 
Dunger C (2015)
Dunger C, Higginson I, Gysels M, et al. Breathlessness and crises in the context of advanced illness: a comparison between COPD and lung cancer patients. Palliat Support Care. 2015 Apr;13(2):229-37. doi: 10.1017/S147895151300120X. Epub 2014 Feb 13.
 
Johnson M (2010)
Johnson M, Oxberry S et al. Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review. Eur J Heart Fail. 2010 Feb;12(2):137-47.
 
Vora V (2004)
Vora V, Ahmedzai S. Pulse oximetry in supportive and palliative care. Support Care Cancer. 2004 Nov;12(11):758-61.
 
Beernaert K (2013)
Beernaert K, Cohen J, Deliens L, et al. Referral to palliative care in COPD and other chronic diseases: a population-based study. Respir Med. 2013 Nov;107(11):1731-9.
 
Clinical Care Ontario (2010)
Symptom management guide-to-practice: dyspnea. Ontario: Clinical Care Ontario, Augustus 2010.
 
Dunger C (2014)
Dunger C, Higginson IJ, Gysels G, et al. Breathlessness and crises in the context of advanced illness: a comparison between COPD and lung cancer. Am J Hosp Palliat Care. 2014 Feb;31(1):13-9. [Epub ahead of print].
 
Eizenga WH (2006)
Eizenga WH, De Bont M, Vriezen JA, et al. METC. Landelijke eerstelijns samenwerkingsafspraak palliatieve zorg. Huisarts en Wetenschap 2006; 49: 308-312.
 
Gardiner C (2010)
Gardiner C, Gott M, Payne S, et al. Exploring the care needs of patients with advanced COPD: an overview of the literature. Respir Med. 2010 Feb;104(2):159-65.
 
Gore JM (2000)
Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000 Dec;55(12):1000-6.
 
Henoch I (2008)
Henoch I, Bergman B, Gustafsson M, et al. Dyspnea experience in patients with lung cancer in palliatieve care. Eur J Oncol Nurs. 2008 Apr;12(2):86-96.
 
Higginson IJ (2014)
Higginson IJ, Bausewein C, Reilly CC,et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med. 2014 Dec;2(12):979-87.
 
Janssen DJ (2015)
Janssen DJ, Van den Beuken-van Everdingen MHJ, Schols JMGA. Verrast door de ‘surprise question’. Ned Tijdschr Geneesk 2015;159: A8427
 
Joshi M (2012)
Joshi M, Joshi A, Bartter T. Symptom burden in chronic obstructive pulmonary disease and cancer. Curr Opin Pulm Med. 2012 Mar;18(2):97-103.
 
KNMG (Koninklijke Nederlandsche Maatschappij tot bevordering der Geneeskunst) (2012)
Handreiking Tijdig spreken over het levenseinde. Utrecht: KNMG, 2012.
 
Mistiaen P (2011)
Mistiaen P, Francke AL, de Graaff FM, et al. Handreiking Palliatieve zorg voor mensen met een niet-westerse achtergrond. Utrecht, NIVEL, 2011.
 
Murray SA (2011)
Murray SA, Boyd K. Using the ‘surprise question’ can identify people with advanced heart failure and COPD who would benefit from a palliatieve care approach. Palliat Med 2011; 25: 382.
 
NHS Scotland (2014)
NHS Scotland. Scottish palliative guidelines, 2014. http://www.palliativecareguidelines.scot.nhs.uk/guidelines/symptom-control/breathlessness.aspx
 
Nederlands Huisartsen Genootschap (NHG), Nederlandse Vereniging voor Cardiologie (NVVC) en Nederlandsche Internisten Vereeniging (NIV) (2010)
NHG, Landelijke richtlijn hartfalen, 2010.
 
Rabow MW (2004)
Rabow MW, Dibble SL, Pantilat SZ, McPhee SJ. The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Arch Intern Med. 2004 Jan 12;164(1):83-91.
 
Small N (2010)
Small N, Gardiner C, Barnes S, et al. Using a prediction of death in the next 12 months as a prompt for referral to palliative care acts to the detriment of patients with heart failure and chronic obstructive pulmonary disease. Palliat Med. 2010 Oct; 24(7): 740-1.
 
Zwerink M (2014)
Zwerink M, Brusse-Keizer M, van der Valk PD, et al. Selfmanagement for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014; 3: CD002990.
 
Beyea A (2012)
Beyea A, Winzelberg G, Stafford RE. To drain or not to drain: an evidence-based approach to palliative procedures for the management of malignant pleural effusions. J Pain Symptom Manage. 2012 Aug;44(2):301-6.
 
Chan KS (2010)
Chan KS, Tse DMW, Sham MMK, et al. Palliative medicine in malignant respiratory disease. In: Hanks G, Cherny NI, Christakis NA, Fallon M. Kaasa S, Portenoy RK (eds). Oxford textbook of palliative medicine (fourth edition). Oxford: Oxford University Press, 2010, pp.1107-1144.
 
Kvale PA (2007)
Kvale PA, Selecky PA, Prakash UBS. Palliative care in lung cancer. AACP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep;132(3 Suppl):368S-403S.
 
Simoff MJ (2013)
Simoff MJ, Lally B, Slade MG, et al. Symptom management in patients with lung cancer. Chest 2013; 143(5)(Suppl): e455S-e497s.
 
Abernethy AP (2010)
Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet. 2010 Sep 4;376(9743):784-93.
 
Bailey CD (2010)
Bailey CD, Wagland R, Dabbour R, et al. An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses. BMC Pulm Med. 2010 Dec 9;10:63.
 
Barton R (2010)
Barton R, English A, Nabb S, et al. A randomised trial of high vs low intensity training in breathing techniques for breathless patients with malignant lung disease: a feasibility study. Lung Cancer. 2010 Dec;70(3):313-9.
 
Ben-Aharon I (2012)
Ben-Aharon I, Gafter-Gvili A, Leibovici L, et al. Interventions for alleviating cancer-related dyspnea: A systematic review and meta-analysis. Acta Oncol. 2012 Nov;51(8):996-1008.
 
Bradley JM (2007)
Bradley JM, Lasserson T, Elborn S, et al. A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest. 2007 Jan;131(1):278-85.
 
Chen H (2011)
Chen H, Liang B-M, Xu Z-B, et al. Long-term non-invasive positive pressure ventilation in severe stable chronic obstructive pulmonary disease: a meta-analysis. Chin Med J (Engl). 2011 Dec;124(23):4063-70.
 
Cranston JM (2008)
Cranston JM, Crockett A, Currow D. Oxygen therapy for dyspnoea in adults. Cochrane Database of Systematic Reviews. 2008; 3(3): CD004769.
 
Currow D (2009)
Currow D, Agar M, Smith J, Abernethy AP. Does palliative home oxygen improve dyspnoea? A consecutive cohort study. Palliat Med. 2009 Jun;23(4):309-16.
 
Deng G (2013)
Deng G, Liu F, Zhong Q, et al. The effect of non-pharmacological staged interventions on fatigue and dyspnoea in patients with chronic obstructive pulmonary disease: a randomized controlled trial. Int J Nurs Pract. 2013 Dec;19(6):636-43.
 
Dreher M (2009)
Dreher M, Doncheva E, Schwoerer A, et al. Preserving oxygenation during walking in severe chronic obstructive pulmonary disease: noninvasive ventilation versus oxygen therapy. Respiration 2009; 78(2): 154-60.
 
Duiverman ML (2011)
Duiverman ML, Wempe JB, Bladder G, et al. Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial. Respiratory research 2011; 12(112).
 
Hardinge M (2015)
Hardinge M, Annandale J, Bourne S, et al. British Society guidelines for home oxygen use in adults. Thorax 2015; 70: i1-i43, doi: 10:1136/thorax/nl-2015-206865.
 
Holland AE (2012)
Holland AE, Hill CJ, Jones AY, McDonald CF. Breathing exercises for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2012; 10.
 
Johnson MJ (2013)
Johnson MJ, Bland JM, Oxberry SG, Abernethy AP, Currow DC. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage 2013; 46: 957-963.
 
Kolodziej MA (2007)
Kolodziej MA, Jensen L, Rowe B, Sin D. Systematic review of noninvasive positive pressure ventilation in severe stable COPD. Eur Respir J. 2007;30(2):293-306.
 
Lee EJ (2011)
Lee EJ, Frazier SK. The efficacy of acupressure for symptom management: a systematic review. J Pain Symptom Manage. 2011; 42(4): 589-603.
 
Long Alliantie Nederland (2011)
Richtlijn palliatieve zorg voor mensen met COPD. Amersfoort: Long Alliantie Nederland, 2011.
 
Mahler DA (2010a)
Mahler DA, Selecky PA, Harrod CG et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest 2010; 137: 674-691.
 
Mahler DA (2010b)
Mahler DA, Selecky PA, Harrod CG. Management of dyspnea in patients with advanced lung or heart disease. Pol Arch Wed Wewn 2010; 120: 160-165.
 
Marciniuk DD (2011)
Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011; 18(2): 69-78.
 
Moore S (2002)
Moore S, Corner J, Haviland J, et al. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ 2002; 325: 1-7.
 
Moore RP (2011)
Moore RP, Berlowitz DJ, Denehy L, et al. A randomized trial of domiciary, ambulatory oxygen in patients with COPD and dyspnea but without resting hypoxemia. Thorax 2011; 66: 32-37.
 
Norweg A (2013)
Norweg A, Collins EG. Evidence for cognitive-behavioral strategies improving dyspnea and related distress in COPD. International Journal of COPD 2013; 8: 439-51.
 
Osadnik CR (2012)
Osadnik CR, McDonald CF, Jones AP, Holland AE. Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2012; 3: CD008328.
 
Ozalevli S (2007)
Ozalevli S, Ozden A, Gocen Z, Cimrin AH. Comparison of six-minute walking tests conducted with and without supplemental oxygen in patients with chronic obstructive pulmonary disease and exercise-induced oxygen desaturation. Ann Saudi Med 2007; 27(2): 94-100.
 
Pan L (2014)
Pan L, Guo Y, Lio X, Yan J. Lack of efficacy of neuromuscular stimulation of the lower limbs in chronic obstructive pulmonary disease: a meta-analysis. Respirology 2014; 19: 22-29.
 
Qaseem A (2008)
Qaseem A, Snow V, Shekelle P et al. Evidence based interventions to improve the palliative care of pain, dyspnea and depression at the end of life: a clinical practice guideline from the American College of Physisicans. Ann Intern Med 2008; 148: 141-146.
 
Struik FM (2013)
Struik FM, Lacasse Y, Goldstein R, Kerstjens HA, Wijkstra PJ. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Review 2013; 6: CD002878.
 
Suzuki et al (2012)
Suzuki et al. A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disaese. Arch Intern Med 2012; 172: 878-886.
 
Towler P (2013)
Towler P, Molassiotis A, Brearley SG. What is the evidence for the use of acupuncture as an intervention for symptom management in cancer supportive and palliative care: an integrative overview of reviews. Support Care Cancer 2013; 21(10): 2913-23.
 
Uronis H (2011)
Uronis H, McCrory DC, Samsa G, Currow D, Abernethy A. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2011; 6(6): CD006429.
 
Zhao I (2008)
Zhao I, Yates P. Non-pharmacological interventions for breathlessness management in patients with lung cancer: a systematic review. Palliat Med 2008; 22: 693-701.
 
Abernathy AP (2003)
Abernathy AP, Currow DC, Frith P, et al. Randomised, double-blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnea. BMJ. 2003 Sep 6;327(7414):523-8.
 
Bailey CD (2010)
Bailey CD, Wagland R, Dabbour R, et al. An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses. BMC Pulm Med. 2010 Dec 9;10:63.
 
Clemens KE (2008)
Clemens KE, Klaschik E. Morphine in the management of dyspnea in ALS. A pilot study. Eur J Neurol. 2008 May;15(5):445-50.
 
Clemens KE (2009)
Clemens KE, Quednau I, Klaschik E. Use of oxygen and opioids in the palliation of dyspnea in hypoxic and non-hypoxic palliative care patients: a prospective study. Support Care Cancer. 2009 Apr;17(4):367-77.
 
Cuervo Pinna et al (2014)
Cuervo Pinna et al. A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dysnea on exertion in patients with advanced cancer. J Pain Symptom Manage. 2014 Jun;47(6):e4-5.
 
Currow DC (2011)
Currow DC. McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage. 2011 Sep;42(3):388-99.
 
Currow DC (2013)
Currow DC, Quinn S, Greene A, et al. The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea. J Palliat Med. 2013 Aug;16(8):881-6.
 
Currow DC (2014)
Currow DC, Ekstrom M, Abernathy AP. Opioids for chronic refractory breathlessness: right patient, right route? Drugs 2014; 74: 1-6.
 
Ekstrom MP (2014)
Ekstrom MP, Bornefalk-Hermansson, Abernathy AP, et al. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ. 2014 Jan 30;348:g445. doi: 10.1136/bmj.g445.
 
Gamborg H (2013)
Gamborg H, Riis J, Christrup L, et al. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases. J Opioid Manag. 2013 Jul-Aug;9(4):269-74.
 
Hui D (2014)
Hui D, Xu A, Frisbee-Hume S, et al. Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial. J Pain Symptom Manage. 2014 Feb;47(2):209-17.
 
Jeba J (2013)
Jeba J, George R, Pease N. Nebulised furosemide in the palliation of dyspnea in cancer: a systematic review. BMJ Support Palliat Care. 2013 Dec 17 doi: 10.1136/bmjspcare-2013-000492. [Epub ahead of print]
 
Jennings AL (2001)
Jennings AL, Davies AN, Higgins JP, et al. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database of Systematic Reviews. 2001; 4(4): CD002066.
 
Kim YH (2013)
Kim YH, Okuda C, Sakamori Y, et al. Cintinuous morphine infusion for end-stage lung cancer patients. Oncol Lett. 2013 Mar;5(3):972-974.
 
KNMG (2009)
Koninklijke Nederlandse Maatschappij ter bevordering van de Geneeskunst. Richtlijn palliatieve sedatie. Utrecht, 2009
 
Leitllinienprogramm Onkologie (2014)
Leitllinienprogramm Onkologie. S3 Leitlinie Palliativmedizin, september 2014. http://leitlinienprogramm-onkologie.de//uploads/tx_sbdownloader/1.Palliativmedizin_Langfassung_Konsultation.pdf.
 
Lin RJ (2012)
Lin RJ, Adelman RD, Mehta SS. Dyspnea in palliative care: expanding the role of corticosteroids. J Palliat Med 2012; 15: 834-7.
 
Lopez-Saca JM (2014)
Lopez-Saca JM, Centeno C. Opioids prescription for symptom relief on respiratory function: updated evidence. Curr Opin Support Palliat Care. 2014 Dec;8(4):383-90.
 
Lorenz KA (2008)
Lorenz KA, Lynn J, Dy SM, et al. Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med. 2008 Jan 15;148(2):147-59.
 
Oxberry SG (2011)
Oxberry SG, Torgerson DJ, Bland JM, et al. Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial. Eur J Heart Fail. 2011 Sep;13(9):1006-12.
 
Oxberry SG (2013)
Oxberry SG, Bland JM, Clark AL, et al. Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough. J Palliat Med. 2013 Mar;16(3):250-5.
 
Simon ST (2010)
Simon ST, Higginson IJ, Booth S, et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database of Systematic Reviews. 2010; 1(1): CD007354.
 
Simon ST (2013)
Simon ST, Koskeroglu P, Gaertner J, et al. Fentanyl for the relief of refractory breathlessness: a systematic review. J Pain Symptom Manage. 2013 Dec;46(6):874-86.
 
Reddy SK (2009)
Reddy SK, Parsons HA, Elsayem A, et al. Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med 2009;12(1):29-36.
 
Galbraith S (2010)
Galbraith S, Fagan P, Perkins P et al. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage. 2010 May;39(5):831-8. doi: 10.1016/j.jpainsymman.2009.09.024.